Your browser doesn't support javascript.
loading
MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic Syndrome.
Zou, Tian-Tian; Zhou, Yu-Jie; Zhou, Xiao-Dong; Liu, Wen-Yue; Van Poucke, Sven; Wu, Wen-Jun; Zheng, Ji-Na; Gu, Xue-Mei; Zhang, Dong-Chu; Zheng, Ming-Hua; Pan, Xiao-Yan.
Afiliación
  • Zou TT; Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhou YJ; School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Zhou XD; Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Liu WY; School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Van Poucke S; Department of Cardiovascular Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wu WJ; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng JN; Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
  • Gu XM; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhang DC; Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng MH; School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Pan XY; Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Horm Metab Res ; 50(9): 683-689, 2018 Sep.
Article en En | MEDLINE | ID: mdl-30184562
ABSTRACT
Although several risk factors for metabolic syndrome (MetS) have been reported, there are few clinical scores that predict its incidence. Therefore, we created and validated a risk score for prediction of 3-year risk for MetS. Three-year follow-up data of 4395 initially MetS-free subjects, enrolled for an annual physical examination from Wenzhou Medical Center were analyzed. Subjects at enrollment were randomly divided into the training and the validation cohort. Univariate and multivariate logistic regression models were employed for model development. The selected variables were assigned an integer or half-integer risk score proportional to the estimated coefficient from the logistic model. Risk scores were tested in a validation cohort. The predictive performance of the model was tested by computing the area under the receiver operating characteristic curve (AUROC). Four independent predictors were chosen to construct the MetS risk score, including BMI (HR=1.906, 95% CI 1.040-1.155), FPG (HR=1.507, 95% CI 1.305-1.741), DBP (HR=1.061, 95% CI 1.002-1.031), HDL-C (HR=0.539, 95% CI 0.303-0.959). The model was created as -1.5 to 4 points, which demonstrated a considerable discrimination both in the training cohort (AUROC=0.674) and validation cohort (AUROC=0.690). Comparison of the observed with the estimated incidence of MetS revealed satisfactory precision. We developed and validated the MetS risk score with 4 risk factors to predict 3-year risk of MetS, useful for assessing the individual risk for MetS in medical practice.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Metabólico / Modelos Biológicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Horm Metab Res Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndrome Metabólico / Modelos Biológicos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Horm Metab Res Año: 2018 Tipo del documento: Article País de afiliación: China